SB cell、autologous、Osseointegration
Showing 1 - 25 of >10,000
Guided Bone Regeneration Trial in Taipei (SB cells)
Unknown status
- Guided Bone Regeneration
- SB cells
-
Taipei, TaiwanTaipei Medical University Hospital
Jun 28, 2020
HIV Trial in Cincinnati (SB-728-T, Expanded unmodified autologous CD4+ T cells)
Active, not recruiting
- HIV Infections
- SB-728-T
- Expanded unmodified autologous CD4+ T cells
-
Cincinnati, OhioUniversity of Cincinnati
Jan 1, 2022
Osteoarthritis Knee Trial in Taipei (Adipose-Derived Mesenchymal Stem Cells)
Completed
- Osteoarthritis Knee
- Adipose-Derived Mesenchymal Stem Cells
-
Taipei, TaiwanTaipei Veterans General Hospital
Oct 26, 2022
Alzheimer, Mild Cognitive Impairment, Neuro-Degenerative Disease Trial in Tijuana (SNK01)
Recruiting
- Alzheimer Disease
- +2 more
- SNK01
-
Tijuana, Baja California, MexicoHospital Angeles Tijuana
Sep 27, 2022
Idiopathic Pulmonary Fibrosis Trial in Beijing, Guangzhou, Shanghai (REGEND001 Autologous Therapy Product)
Recruiting
- Idiopathic Pulmonary Fibrosis
- REGEND001 Autologous Therapy Product
-
Beijing, Beijing, China
- +2 more
Dec 19, 2022
Solid Tumor, Adult, Colorectal Cancer, NSCLC Trial in United States (A2B694, xT CDx with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +19 more
- A2B694
- xT CDx with HLA-LOH Assay
-
Duarte, California
- +9 more
Sep 22, 2023
Chemo-induced Nausea and Vomiting Trial in Istanbul (Breathing exercise group, Control group)
Recruiting
- Chemotherapy-induced Nausea and Vomiting
- Breathing exercise group
- Control group
-
Istanbul, TurkeyKoç University Hospital
Apr 6, 2022
Dental Implant Failed, Osseointegration Failure of Dental Implant Trial in Istanbul (Patients selection, Implnat placement,
Completed
- Dental Implant Failed
- Osseointegration Failure of Dental Implant
- Patients selection
- +2 more
-
Istanbul, TurkeyIstanbul Medipol University, School of Dentistry
Oct 20, 2023
HIV Trial in United States (SB-728mR-HSPC Infusion 3 days following busulfan conditioning)
Active, not recruiting
- HIV
- SB-728mR-HSPC Infusion 3 days following busulfan conditioning
-
Duarte, California
- +4 more
Mar 7, 2022
Periodontal Pocket Trial in Van (autologous products)
Completed
- Periodontal Pocket
- autologous products
-
Van, TurkeyAhmet Cemil TALMAC
Jul 11, 2023
Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)
Not yet recruiting
- Solid Tumor, Adult
- +15 more
- A2B530
- xT-Onco with HLA-LOH Assay
-
Duarte, California
- +6 more
Feb 10, 2023
COPD Trial in China (REGEND001 Autologous Therapy Product, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- REGEND001 Autologous Therapy Product
- Placebo
-
Beijing, Beijing, China
- +5 more
Dec 7, 2022
Multiple Myeloma Trial in United Kingdom (Autologous Stem Cell Transplant (ASCT), Consolidation with 4 cycles of CarCyDex)
Active, not recruiting
- Multiple Myeloma
- Autologous Stem Cell Transplant (ASCT)
- Consolidation with 4 cycles of CarCyDex
-
Romford, Essex, United Kingdom
- +19 more
May 4, 2021
(LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX
Active, not recruiting
- Hemophilia B
- +2 more
- SB-318
- +2 more
-
Oakland, California
- +4 more
Jan 30, 2023
Human Immunodeficiency Virus (HIV) Trial in United States (SB-728mR-T, Cyclophosphamide)
Completed
- Human Immunodeficiency Virus (HIV)
- SB-728mR-T
- Cyclophosphamide
-
San Francisco, California
- +4 more
Mar 17, 2021
Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)
Not yet recruiting
- Lymphoma
- Peripheral Blood Stem Cell Transplantation
- Eltrombopag olamine
- (no location specified)
Jul 25, 2023
Head Neck Cancer, Relapse, Recurrent Trial in Chapel Hill (Cyclophosphamide, Fludarabine, Cell Therapy)
Not yet recruiting
- Head and Neck Cancer
- +3 more
- Cyclophosphamide
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Oct 18, 2023
Type 2 Diabetes, Cardiovascular Diseases Trial in Minneapolis (prolonged SB, SB broken 1, SB broken 2)
Not yet recruiting
- Type 2 Diabetes
- Cardiovascular Diseases
- prolonged SB
- +2 more
-
Minneapolis, MinnesotaUniversity of Minnesota
Apr 28, 2023
Coronary Artery Disease Trial (Simple Crossover, Side branch opening)
Not yet recruiting
- Coronary Artery Disease
- Simple Crossover
- Side branch opening
- (no location specified)
Jan 26, 2023
Preparation of Patient Autologous Induced Pluripotent Stem
Not yet recruiting
- Age-Related Macular Degeneration
- somatic cell collection
- (no location specified)
Aug 14, 2023
ASCT Versus Chemotherapy as First-Line Consolidation Therapy
Completed
- T-cell Lymphoma Adults
- consolidation with ASCT
- (no location specified)
Nov 25, 2023
NK Cell, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory Trial in Hubei (autologous NK cell)
Not yet recruiting
- NK Cell
- +2 more
- autologous NK cell
-
Hubei, Xiangyang, ChinaEC of Xiangyang No.1 People's Hospital Hubei University of Medic
Jun 19, 2023
Evaluation for NCI Surgery Branch Clinical Research Protocols
Recruiting
- Synovial Cell Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Identify Barriers to Cellular Therapies for People With Plasma
Recruiting
- Multiple Myeloma
- Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
- +5 more
-
Basking Ridge, New Jersey
- +6 more
Nov 6, 2023
Autologous Epidermal Cell Transplantation Trial (Cultured autologous epidermal cell membrane)
Not yet recruiting
- Autologous Epidermal Cell Transplantation
- Cultured autologous epidermal cell membrane
- (no location specified)
May 31, 2023